Name:
Christopher John Lawson
Country:
GBR
City:
Reading
State/Province:
ACS Member:
Member
Local Section:
International Chapter:
Technical Division Membership:
D504,Carbohydrate Chemistry & Chemical Glycobiology
Technical Division Membership Emeritus:
Subdivision Member:
ACS Activities:
Company/Institution Name:
Career Stage:
Professional
Research and Special Interests:
Chris Lawson has many years of high-level experience delivering and managing chemistry and life science research projects. As a joint founder and CEO of Dextra Laboratories, he helped develop the start-up into a highly successful glycobiology company with a catalogue of key research carbohydrates and a specialist custom synthesis business focused on sugar chemistry. Dextra was sold to New Zealand Pharmaceuticals in 2007.
Working in industry, Chris was a senior research manager at Tate & Lyle Research where his research groups helped to bring a number of important products to market including xanthan gum and sucralose.
During his PhD at the University of Edinburgh, he studied the chemistry and enzymology of polysaccharides. As a member of the research team led by Prof. Sir Dai Rees, he helped to demonstrate how polysaccharides form networks and highly organised structures in living tissues – a breakthrough in glycoscience which had enormous significance in the food and life science industries.
Chris is the author of over 40 publications including research papers, patents and book chapters. He is a member of The ACS, the Society of Chemical Industry (SCI) and is a Fellow of the Royal Society of Chemistry.
Area of Expertise:
Over 40 publications (research papers & patents, book chapters),Member-UK Glycoscience Network,Fellow: The Royal Society of Chemistry (FRSC. C.Chem. Registered Analytical Chemist),Committee member-RSC Carbohydrate Group,Management Committee of VGCLLP (Acumentia),Expert evaluator European Commission. Framework V-Life Sciences Directorate (Framework IV 1999-2000-Framework V 2000-2001): Key Action 1-Food Nutrition & Health. Key Action 2-Control of Infectious Disease. Framework VI (2003), Expert evaluator and rapporteur European Commission. Framework VI (2005)-Life Science & Health Consesus Group I-Unravelling the mechanisms and functions of post-translational modifications of proteins-Temporal and spatial proteomics in the cell, Member: Thames Valley Life Science Network UK, Referee Panels for: (a) Royal Society of Chemistry-Primary Publications (b) Enzyme and Microbial Technology,Member: (a) American Chemical Society (Division of Carbohydrates)-(b) Society of Chemistry and Industry-(c) The Biochemical Society-(d) Society of Glyobiology-(e) French Glycobiology Society.
Years of Expertise: